(Q54050407)

24 May 2018

title

Therapy of murine cutaneous leishmaniasis by DNA vaccination. (English)

1 reference

24 May 2018

ORCID Public Data File 2021

main subject

cutaneous leishmaniasis

1 reference

1 reference

author name string

Handman E

1

1 reference

24 May 2018

Noormohammadi AH

2

1 reference

24 May 2018

Curtis JM

3

1 reference

24 May 2018

Baldwin T

4

1 reference

24 May 2018

Sjölander A

5

1 reference

24 May 2018

language of work or name

English

0 references

publication date

1 July 2000

1 reference

24 May 2018

number of pages

7

1 reference

inferred from page(s)

published in

Vaccine

1 reference

24 May 2018

volume

18

1 reference

24 May 2018

issue

26

1 reference

24 May 2018

page(s)

3011-3017

1 reference

24 May 2018

Leishmania infantum tropism: strain genotype or host immune status?

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

Isolation and characterization of infective and non-infective clones of Leishmania tropica

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

The Leishmania promastigote surface antigen 2 complex is differentially expressed during the parasite life cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

The regulation of immunity to Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

Functional diversity of helper T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

Resistance of BALB/c mice to Leishmania major infection is associated with a decrease in the precursor frequency of antigen-specific CD4+ cells secreting interleukin-4

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

IL-12 as an adjuvant for cell-mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

Recombinant interleukin 12 cures mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900109-2

7 January 2021

10.1016/S0264-410X(00)00109-2

Identifiers

DOI

1 reference

24 May 2018

PubMed ID

10825604

1 reference

24 May 2018